Brookdale Senior Living (BKD)
(Delayed Data from NYSE)
$6.58 USD
-0.03 (-0.45%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $6.58 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth F Momentum B VGM
Price, Consensus and EPS Surprise
BKD 6.58 -0.03(-0.45%)
Will BKD be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for BKD based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for BKD
Brookdale Q3 2024 Occupancy Jumps, Logs 35th Straight Monthly Boost
Brookdale Bets Big With $610M Acquisitions Amid Debt Refinancing
BKD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Why Brookdale May Not Be a Safe Bet Despite 34-Month Occupancy Growth
Brookdale (BKD) Down 7% Since Q2 Earnings Miss on Lower Interest
Brookdale Senior (BKD) Q2 Occupancy Jumps, Growth Trend Persists
Other News for BKD
Brookdale initiated with Buy at Jefferies on 'golden age for senior housing'
Bruker’s Growth Potential Supported by Nanostring Integration and Cost Management: Buy Rating Reaffirmed
Promising Growth Prospects for Brookdale Senior Living Amid Demographic Shifts and Operational Improvements
Brookdale Senior Living initiated with bullish view at Jefferies, here's why
Analysts Offer Insights on Healthcare Companies: Teladoc (TDOC), Brookdale Senior Living (BKD) and Vertex Pharmaceuticals (VRTX)